+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06862869

Prospective Multicenter Study on Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Receiving Alectinib Adjuvant Therapy in China

Led by Hoffmann-La Roche · Updated on 2026-10-06

800

Participants Needed

44

Research Sites

17 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the real-world clinical outcomes of adult patients in China who have had surgery for stage II to IIIB anaplastic lymphoma kinase ALK-positive non-small-cell lung cancer NSCLC and were treated with Alectinib as adjuvant therapy. This multicenter, prospective cohort study aims to better understand the disease-free survival and other clinical characteristics of these patients over time. Participants in this observational study have already received Alectinib following their surgery as part of routine clinical care. The study does not provide any additional treatments but follows patients who have taken Alectinib monotherapy without prior systemic therapy, including other ALK-targeted therapies or chemotherapy. Patients will be observed during their routine clinical visits for about 2.5 years. During the study, researchers will collect information on disease recurrence or death, treatment duration, participant demographics, clinical characteristics including performance status and surgery history, and quality of life using questionnaires every three months. Adverse events related to Alectinib will also be monitored from baseline until 28 days after the last dose or withdrawal. The total follow-up period for each participant is approximately 2.5 years.

CONDITIONS

Brief Title

Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy

Research Team

R

Reference Study ID Number: ML45766 https://forpatients.roche.com/ No attachments to email below.

F

Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here